Statement Of Financial Position [Abstract]
| Concept |
As at 2024-12-31 |
As at 2024-12-31 |
As at 2024-12-31 |
As at 2024-12-31 |
As at 2024-12-31 |
As at 2024-12-31 |
As at 2023-12-31 |
As at 2023-12-31 |
As at 2023-12-31 |
As at 2023-12-31 |
As at 2023-12-31 |
As at 2023-12-31 |
As at 2022-12-31 |
As at 2022-12-31 |
As at 2022-12-31 |
As at 2022-12-31 |
As at 2022-12-31 |
As at 2022-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Statement of financial position [abstract] | ||||||||||||||||||
| Assets [abstract] | ||||||||||||||||||
| Non-current assets [abstract] | ||||||||||||||||||
| Property, plant and equipment | — | — |
197,658,000
USD
|
— | — | — | — | — | — | — |
275,599,000
USD
|
— | — | — | — | — | — | — |
| Right-of-use assets | — | — |
1,501,000
USD
|
— | — | — | — | — | — | — |
1,971,000
USD
|
— | — | — | — | — | — | — |
| Trade and other non-current receivables | — | — |
1,049,000
USD
|
— | — | — | — | — | — | — |
481,000
USD
|
— | — | — | — | — | — | — |
| Non-current assets | — | — |
216,992,000
USD
|
— | — | — | — | — | — | — |
294,582,000
USD
|
— | — | — | — | — | — | — |
| Current assets [abstract] | ||||||||||||||||||
| Current inventories | — | — |
5,729,000
USD
|
— | — | — | — | — | — | — |
5,139,000
USD
|
— | — | — | — | — | — | — |
| Trade and other current receivables | — | — |
3,666,000
USD
|
— | — | — | — | — | — | — |
1,155,000
USD
|
— | — | — | — | — | — | — |
| Current biological assets | — | — |
16,991,000
USD
|
— | — | — | — | — | — | — |
16,218,000
USD
|
— | — | — | — | — | — | — |
| Cash and cash equivalents | — | — |
29,862,000
USD
|
— | — | — | — | — | — | — |
22,951,000
USD
|
— |
24,103,000
USD
|
— | — | — | — | — |
| Current assets | — | — |
56,681,000
USD
|
— | — | — | — | — | — | — |
47,676,000
USD
|
— | — | — | — | — | — | — |
| Assets | — | — |
273,673,000
USD
|
— | — | — | — | — | — | — |
342,258,000
USD
|
— | — | — | — | — | — | — |
| Equity and liabilities [abstract] | ||||||||||||||||||
| Equity [abstract] | ||||||||||||||||||
| Issued capital | — | — |
38,110,000
USD
|
— | — | — | — | — | — | — |
8,644,000
USD
|
— | — | — | — | — | — | — |
| Retained earnings | — | — |
581,488,000
USD
|
— | — | — | — | — | — | — |
414,167,000
USD
|
— | — | — | — | — | — | — |
| Share premium | — | — |
751,560,000
USD
|
— | — | — | — | — | — | — |
691,430,000
USD
|
— | — | — | — | — | — | — |
| Equity |
581,488,000
USD
|
751,560,000
USD
|
202,832,000
USD
|
4,104,000
USD
|
38,110,000
USD
|
9,454,000
USD
|
691,430,000
USD
|
8,644,000
USD
|
6,726,000
USD
|
414,167,000
USD
|
283,140,000
USD
|
3,959,000
USD
|
296,382,000
USD
|
577,805,000
USD
|
1,716,000
USD
|
7,049,000
USD
|
280,409,000
USD
|
4,319,000
USD
|
| Liabilities [abstract] | ||||||||||||||||||
| Non-current liabilities [abstract] | ||||||||||||||||||
| Non-current liabilities | — | — |
63,379,000
USD
|
— | — | — | — | — | — | — |
39,332,000
USD
|
— | — | — | — | — | — | — |
| Current liabilities [abstract] | ||||||||||||||||||
| Trade and other current payables | — | — |
6,968,000
USD
|
— | — | — | — | — | — | — |
14,336,000
USD
|
— | — | — | — | — | — | — |
| Current liabilities | — | — |
7,462,000
USD
|
— | — | — | — | — | — | — |
19,786,000
USD
|
— | — | — | — | — | — | — |
| Liabilities | — | — |
70,841,000
USD
|
— | — | — | — | — | — | — |
59,118,000
USD
|
— | — | — | — | — | — | — |
| Equity and liabilities | — | — |
273,673,000
USD
|
— | — | — | — | — | — | — |
342,258,000
USD
|
— | — | — | — | — | — | — |